Showing results (71-80 of 418) with videos related to
Sort By:
Pageof 42
Trends in Immunology|June 18, 2003
Tumors as elusive targets of T-cell-based active immunotherapyFrancesco M Marincola, Ena Wang, Meenhard Herlyn, et al.Drug Discovery Today|November 11, 2022
Engineered nanomedicines to overcome resistance of pancreatic cancer to immunotherapyAhmed O Elzoghby, Cristina R Ferrone, Soldano Ferrone, et al.The Journal of Urology|January 10, 2004
Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?Derek Atkins, Soldano Ferrone, Gerd E Schmahl, et al.Current Medicinal Chemistry|March 7, 2019
B7-H3-targeted Radioimmunotherapy of Human CancerBenjamin B Kasten, Soldano Ferrone, Kurt R Zinn, et al.Gynecologic Oncology|August 23, 2012
A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancerJanelle M Fauci, J Michael Straughn, Soldano Ferrone, et al.Head & Neck|September 18, 2010
Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neckMark E Sharafinski, Robert L Ferris, Soldano Ferrone, et al.The Journal of Biological Chemistry|February 13, 2003
A single-nucleotide deletion leads to rapid degradation of TAP-1 mRNA in a melanoma cell lineTianyu Yang, Beth A McNally, Soldano Ferrone, et al.Cancer Immunology, Immunotherapy : CII|August 30, 2008
Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cellsIrina L Tourkova, Galina V Shurin, Soldano Ferrone, et al.Annals of Surgical Oncology|March 30, 2016
Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine TumorsVincenzo Villani, Krishnan K Mahadevan, Matteo Ligorio, et al.Oncoimmunology|February 7, 2014
EGFR-mediated tumor immunoescape: The imbalance between phosphorylated STAT1 and phosphorylated STAT3Fernando Concha-Benavente, Raghvendra M Srivastava, Soldano Ferrone, et al.Pageof 42